Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Indivior PLC

www.indivior.com

Latest From Indivior PLC

Indivior Submits Products For Approval Outside The US, Where Pressures Mount

Indivior is working on receiving ex-US approvals for its opioid abuse treatment products and building its cash reserves but faces future uncertainty over US generic competition and a US Department of Justice legal action.

 

Neurology Research and Development Strategies

US FDA Must Explain How It Defines ‘Innovation’ In Awarding Hatch/Waxman Exclusivity, Court Says

Agency's decision that Indivior’s Sublocade blocked Braeburn’s long-acting buprenorphine formulation Brixadi lacked ‘substantive guideposts’ in how innovation is defined for purposes of deciding scope of three-year exclusivity, US judge says.

Legal Issues FDA

DOJ's Investigation Of Reckitt's Suboxone Promotions Marks The Return Of The Big Settlement

$1.4b payment to settle investigation of marketing of opioid addition treatment is biggest for a pharma in several years.

Advertising, Marketing & Sales Legal Issues

FTC's First Product Hopping Complaint Targets Safety Claims For Suboxone Film Formulation

Commission files complaint as it reaches $50m settlement with Reckitt Benckiser.

Legal Issues Enforcement
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Reckitt Benckiser Pharmaceuticals Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Indivior PLC
  • Senior Management
  • Shaun Thaxter, CEO
    Mark Crossley, CFO
    Ponni Subbiah, MD, CMO
    Christian Heidbreder, PhD, CSO
    Richard Simkin, Chief Commercial Officer
  • Contact Info
  • Indivior PLC
    Phone: (0)1753 217800
    215 Bath Rd.
    Slough, SL1 4AA
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register